BR112017018172B8 - Método para romper um biofilme através de composições compreendendo combinações de ácidos orgânicos - Google Patents

Método para romper um biofilme através de composições compreendendo combinações de ácidos orgânicos

Info

Publication number
BR112017018172B8
BR112017018172B8 BR112017018172A BR112017018172A BR112017018172B8 BR 112017018172 B8 BR112017018172 B8 BR 112017018172B8 BR 112017018172 A BR112017018172 A BR 112017018172A BR 112017018172 A BR112017018172 A BR 112017018172A BR 112017018172 B8 BR112017018172 B8 BR 112017018172B8
Authority
BR
Brazil
Prior art keywords
biofilm
compositions
combinations
organic acids
break
Prior art date
Application number
BR112017018172A
Other languages
English (en)
Other versions
BR112017018172A2 (pt
BR112017018172B1 (pt
Inventor
Fourre Tara
J Gambogi Robert
R Geonnotti Anthony Iii
L Golas Patricia
Serbiak Benjamin
Original Assignee
Johnson & Johnson Consumer Inc
Currahee Holding Company Inc
Chenango Zero Llc
Chenango Two Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer Inc, Currahee Holding Company Inc, Chenango Zero Llc, Chenango Two Llc filed Critical Johnson & Johnson Consumer Inc
Publication of BR112017018172A2 publication Critical patent/BR112017018172A2/pt
Publication of BR112017018172B1 publication Critical patent/BR112017018172B1/pt
Publication of BR112017018172B8 publication Critical patent/BR112017018172B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions
    • A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/596—Mixtures of surface active compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

COMPOSIÇÕES COMPREENDENDO COMBINAÇÕES DE ÁCIDOS ORGÂNICOS. São fornecidas composições que compreendem ácido succínico, ácido aconítico e um veículo, em que o ácido succínico e ácido aconítico estão presentes em uma razão de cerca de 0,9:1 a cerca de 40:1. Também são fornecidos métodos de ruptura de um biofilme que compreendem aplicar a uma superfície contendo um biofilme uma composição da presente invenção
BR112017018172A 2015-02-26 2016-02-25 Método para romper um biofilme através de composições compreendendo combinações de ácidos orgânicos BR112017018172B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14/632,508 US9326925B1 (en) 2015-02-26 2015-02-26 Compositions comprising combinations of organic acids
US14/632,508 2015-02-26
PCT/US2016/019480 WO2016138214A1 (en) 2015-02-26 2016-02-25 Compositions comprising combinations of organic acids

Publications (3)

Publication Number Publication Date
BR112017018172A2 BR112017018172A2 (pt) 2018-04-10
BR112017018172B1 BR112017018172B1 (pt) 2021-05-04
BR112017018172B8 true BR112017018172B8 (pt) 2022-08-09

Family

ID=55527657

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017018172A BR112017018172B8 (pt) 2015-02-26 2016-02-25 Método para romper um biofilme através de composições compreendendo combinações de ácidos orgânicos

Country Status (11)

Country Link
US (1) US9326925B1 (pt)
EP (1) EP3261609B1 (pt)
JP (2) JP6816006B2 (pt)
CN (1) CN107405274A (pt)
AU (2) AU2016222690A1 (pt)
BR (1) BR112017018172B8 (pt)
CA (1) CA2977267A1 (pt)
DK (1) DK3261609T3 (pt)
ES (1) ES2875648T3 (pt)
RU (1) RU2748698C2 (pt)
WO (1) WO2016138214A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2684150C (en) 2007-05-14 2016-10-04 Research Foundation Of State University Of New York Decenoic acid dispersion inducers in the treatment of biofilms
US9326924B1 (en) * 2015-02-26 2016-05-03 Johnson & Johnson Consumer Inc. Compositions comprising combinations of organic acids
US9326925B1 (en) * 2015-02-26 2016-05-03 Johnson & Johnson Consumer Inc. Compositions comprising combinations of organic acids
GB2565511B (en) 2016-05-26 2022-04-13 Kimberly Clark Co Anti-adherent compositions and methods of inhibiting the adherence of microbes to a surface
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
EP4356733A1 (de) * 2022-10-19 2024-04-24 Bode Chemie GmbH Niedrigalkoholisches desinfektionsmittel

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE519897A (pt) 1952-05-13
US3678154A (en) 1968-07-01 1972-07-18 Procter & Gamble Oral compositions for calculus retardation
US3737533A (en) 1971-04-28 1973-06-05 Upjohn Co Compositions and methods of combatting insects using 1'-variable-1',1'-dihalohalobenzeneazomethanes
US4051234A (en) 1975-06-06 1977-09-27 The Procter & Gamble Company Oral compositions for plaque, caries, and calculus retardation with reduced staining tendencies
US4138477A (en) 1976-05-28 1979-02-06 Colgate Palmolive Company Composition to control mouth odor
US4150151A (en) * 1977-12-12 1979-04-17 Lever Brothers Company Mouthwash
US4183914A (en) 1977-12-19 1980-01-15 Abdul Gaffar Magnesium polycarboxylate complexes and anticalculus agents
US4661341A (en) 1984-10-30 1987-04-28 The Procter & Gamble Company Oral compositions
US4775525A (en) 1985-12-16 1988-10-04 Ivo Pera Oral hygiene formulation containing sodium alginate
US4847070A (en) 1987-10-08 1989-07-11 The Procter & Gamble Company Anticalculus compositions
US4994262A (en) 1988-10-14 1991-02-19 The Procter & Gamble Company Oral compositions
US5190747A (en) 1989-11-06 1993-03-02 Lion Corporation Oral or detergent composition comprising a nonionic surface active agent
US5015467A (en) 1990-06-26 1991-05-14 The Procter & Gamble Company Combined anticalculus and antiplaque compositions
US5328682A (en) 1990-10-25 1994-07-12 Boots Company Plc Mouthwash
GB9204414D0 (en) 1992-02-29 1992-04-15 Smithkline Beecham Plc Method of treatment
US5451401A (en) 1993-09-29 1995-09-19 The Procter & Gamble Company Diphosphonic acid esters as tartar control agents
US5338537A (en) 1993-10-05 1994-08-16 The Procter & Gamble Company Oral compositions
US5560905A (en) 1994-05-13 1996-10-01 The Proctor & Gamble Company Oral compositions
EP0691124A1 (en) 1994-07-07 1996-01-10 Sara Lee/DE N.V. Mouth care products
US5626838A (en) 1995-03-13 1997-05-06 The Procter & Gamble Company Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx
JPH08289768A (ja) * 1995-04-19 1996-11-05 Kiyuu & C:Kk 食品用殺菌料
US5849271A (en) 1995-06-07 1998-12-15 The Procter & Gamble Company Oral compositions
AU4428397A (en) 1996-09-20 1998-04-14 Warner-Lambert Company Oral compositions containing a zinc compound
AU9300998A (en) 1997-09-09 1999-03-29 Smithkline Beecham Corporation Tooth whitening preparations
US7125543B2 (en) 1998-05-04 2006-10-24 Milton Hodosh Method and composition for preventing tooth hypersensitivity when using passive bleaching agents
JP2000063250A (ja) 1998-08-18 2000-02-29 Lion Corp 口腔用組成物
US6221340B1 (en) * 1999-04-08 2001-04-24 Warner-Lambert Company Zinc containing dentifrice compositions
US6416745B1 (en) 2001-05-03 2002-07-09 Block Drug Company, Inc. Dental composition for treating hypersensitive teeth
US6682722B2 (en) 2001-09-19 2004-01-27 The Procter & Gamble Company Oral compositions providing enhanced overall cleaning
FR2830759B1 (fr) 2001-10-15 2003-12-12 Oreal Composition sous forme d'emulsion huile-dans-eau contenant un copolymere silicone et ses utilisations notamment cosmetiques
JP2005015369A (ja) * 2003-06-25 2005-01-20 Lion Corp 口腔用組成物
US7084104B2 (en) 2003-08-28 2006-08-01 Johnson & Johnson Consumer Company Inc. Mild and effective cleansing compositions
US7417020B2 (en) 2006-05-05 2008-08-26 Johnson & Johnson Consumer Companies, Inc. Compositions comprising low-DP polymerized surfactants and methods of use thereof
US8632754B2 (en) * 2009-08-03 2014-01-21 Mcneil-Ppc, Inc. Tooth sensitivity treatment compositions
JP5397181B2 (ja) * 2009-11-18 2014-01-22 ライオン株式会社 口腔スプレー用組成物及び口腔用製剤
WO2012001347A1 (en) 2010-06-29 2012-01-05 Ucl Business Plc Products with oral health benefits
WO2013072932A2 (en) * 2011-09-30 2013-05-23 Rubicon Research Private Limited Oral care compositions
US10945932B2 (en) * 2013-12-27 2021-03-16 Colgate-Palmolive Company Prebiotic oral care compositions containing carboxylic acids
US9326924B1 (en) * 2015-02-26 2016-05-03 Johnson & Johnson Consumer Inc. Compositions comprising combinations of organic acids
US9326925B1 (en) * 2015-02-26 2016-05-03 Johnson & Johnson Consumer Inc. Compositions comprising combinations of organic acids

Also Published As

Publication number Publication date
EP3261609A1 (en) 2018-01-03
WO2016138214A1 (en) 2016-09-01
EP3261609B1 (en) 2021-04-07
AU2016222690A1 (en) 2017-08-24
CN107405274A (zh) 2017-11-28
JP7210813B2 (ja) 2023-01-24
JP6816006B2 (ja) 2021-01-20
JP2018506568A (ja) 2018-03-08
ES2875648T3 (es) 2021-11-10
BR112017018172A2 (pt) 2018-04-10
DK3261609T3 (da) 2021-06-14
BR112017018172B1 (pt) 2021-05-04
CA2977267A1 (en) 2016-09-01
RU2017133242A3 (pt) 2019-08-13
JP2020196755A (ja) 2020-12-10
RU2748698C2 (ru) 2021-05-28
AU2021201963A1 (en) 2021-04-29
US9326925B1 (en) 2016-05-03
RU2017133242A (ru) 2019-03-28
AU2021201963B2 (en) 2023-04-27

Similar Documents

Publication Publication Date Title
BR112017018187B8 (pt) Composições compreendendo combinações de ácidos orgânicos
BR112017018172B8 (pt) Método para romper um biofilme através de composições compreendendo combinações de ácidos orgânicos
BR112018067538A2 (pt) inibidores de ire1-alfa de pequenas moléculas
PH12018500718A1 (en) Compounds useful as modulators of trpm8
BR112018074001A2 (pt) composição e método de tratamento de substratos
PH12016501985A1 (en) Rapid set aqueous coatings
UY36705A (es) Compuestos de 4-hidroxi-3-(heteroaril)piridin-2-ona como agonistas de apj
UY36949A (es) 2,4-dihidroxi-nicotinamidas como agonistas de apj
MX2018005829A (es) Composiciones para tratar el cabello.
UY37134A (es) Compuestos heteroarilos y composiciones que los contienen útiles como inhibidores de pad4
MX2018005292A (es) Inhibidores de acc y usos de los mismos.
BR112018010720A8 (pt) agonistas do receptor de apelina e métodos de uso
BR112018068341A2 (pt) 6-hidróxi-4-oxo-1,4-di-hidropirimidina-5-carboxamidas como agonistas de apj
MX2022000053A (es) Moduladores de interaccion de sestrina-gator2 y sus usos.
UY36419A (es) Composiciones farmacéuticas que contienen anticuerpos anti-cd38 para el tratamiento de la leucemia mieloide aguda
EA201891251A1 (ru) Бициклические ингибиторы pad4
AU2017317563A8 (en) Detergent compositions comprising xanthan lyase variants I
BR112017010311A2 (pt) 4-oxo-3,4-dihidro-1,2,3-benzotriazinas como moduladores de gpr139
CL2018000688A1 (es) Compuestos heterociclicos que contienen bencilamina y composiciones útiles contra infección por micobacterias
UY37017A (es) Inhibidores aza-bencimidazol de pad4
BR112018075017A2 (pt) partículas de nicotina
BR112017018113B8 (pt) Composições compreendendo combinações de ácidos orgânicos
BR112017006552A2 (pt) composições e métodos para inibir a atividade biológica de biomoléculas solúveis
BR112018015160A2 (pt) compostos trisamida e composições compreendendo os mesmos
CL2016001763A1 (es) Antagonistas selectivos de nr2b

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 25/02/2016, OBSERVADAS AS CONDICOES LEGAIS.

B25A Requested transfer of rights approved

Owner name: CHENANGO ZERO LLC (US)

B25A Requested transfer of rights approved

Owner name: CHENANGO TWO LLC (US)

B25A Requested transfer of rights approved

Owner name: CURRAHEE HOLDING COMPANY INC. (US)

B25D Requested change of name of applicant approved

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)

B25A Requested transfer of rights approved

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)

B25D Requested change of name of applicant approved

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)